Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Malim

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Journal of Virology|August 1, 1989
Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader regionM H Malim, R Fenrick, D W Ballard, et al.
Journal of Virology|March 12, 1999
Mutational analysis of the human immunodeficiency virus type 1 Vif proteinJ H Simon, A M Sheehy, E A Carpenter, et al.
Genes & Development|June 1, 1990
Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev actionY F Ahmed, S M Hanly, M H Malim, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1992
Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev proteinL S Tiley, M H Malim, H K Tewary, et al.
Gene Therapy|June 24, 2011
Gold nanoparticle-mediated gene delivery induces widespread changes in the expression of innate immunity genesE-Y Kim, R Schulz, P Swantek, et al.
Journal of Virology|October 3, 2001
Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag)Y Jenkins, O Pornillos, R L Rich, et al.
Journal of Virology|March 27, 2001
Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4R E Means, T Matthews, J A Hoxie, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1989
Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus speciesM H Malim, S Böhnlein, R Fenrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 1997
Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB controlZ L Chu, T A McKinsey, L Liu, et al.
Cell|February 23, 1990
HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequenceM H Malim, L S Tiley, D F McCarn, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of Virology|August 1, 1989
Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader regionM H Malim, R Fenrick, D W Ballard, et al.
Journal of Virology|March 12, 1999
Mutational analysis of the human immunodeficiency virus type 1 Vif proteinJ H Simon, A M Sheehy, E A Carpenter, et al.
Genes & Development|June 1, 1990
Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev actionY F Ahmed, S M Hanly, M H Malim, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1992
Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev proteinL S Tiley, M H Malim, H K Tewary, et al.
Gene Therapy|June 24, 2011
Gold nanoparticle-mediated gene delivery induces widespread changes in the expression of innate immunity genesE-Y Kim, R Schulz, P Swantek, et al.
Journal of Virology|October 3, 2001
Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag)Y Jenkins, O Pornillos, R L Rich, et al.
Journal of Virology|March 27, 2001
Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4R E Means, T Matthews, J A Hoxie, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1989
Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus speciesM H Malim, S Böhnlein, R Fenrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 1997
Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB controlZ L Chu, T A McKinsey, L Liu, et al.
Cell|February 23, 1990
HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequenceM H Malim, L S Tiley, D F McCarn, et al.
Pageof 7